This may indicate that in humans, on one hand, a subset of Treg cells that express CTLA‐4 is required to prevent a defined spectrum of autoimmune diseases that are seen in patients with CTLA‐4 haploinsufficiency. The gene discussed is CTLA4; the disease is autoimmune disease.